Clinical Trials Browser

Phase 3 × Lymphoma, Mantle-Cell × Bortezomib × Clear all

NCT00722137 2018-07-12

Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma

Phase 3 Completed

487 enrolled 20 charts

Lymphoma, Mantle-Cell

NCT01449344 2017-03-07

(R-HAD)

Phase 3 Unknown

Recurrence, Lymphoma, Mantle-Cell